XLONasdaqPharmaceutical PreparationsFiscal year ends December 31
Xilio Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.33−0.22 (-2.57%)
Close on Oct 19, 2026
- Market cap
- $161.64M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Xilio Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2026 | Jun 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2026 | Apr 28, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2026 | Apr 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2026 | Mar 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2026 | Feb 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 23, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 5, 2026 | Jan 5, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 21, 2025 | Nov 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Nov 21, 2025 | Oct 20, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 2, 2025 | Oct 3, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 9, 2025 | Sep 9, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 22, 2025 | Aug 28, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 3, 2025 | SEC EDGAR |
| Current report | 8-K | May 31, 2025 | Jun 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 10, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 4, 2025 | Apr 8, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2025 | Feb 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2025 | Jan 21, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2024 | Dec 19, 2024 | SEC EDGAR |